BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6381341)

  • 1. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
    Pessayre D
    Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.
    Larrey D; Tinel M; Pessayre D
    Biochem Pharmacol; 1983 May; 32(9):1487-93. PubMed ID: 6860368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions and hepatitis produced by some macrolide antibiotics.
    Pessayre D; Larrey D; Funck-Brentano C; Benhamou JP
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():181-94. PubMed ID: 3877043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions of the macrolide antibiotics.
    Ludden TM
    Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
    Tinel M; Descatoire V; Larrey D; Loeper J; Labbe G; Letteron P; Pessayre D
    J Pharmacol Exp Ther; 1989 Aug; 250(2):746-51. PubMed ID: 2527301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
    Delaforge M; Sartori E; Mansuy D
    Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
    Dansette PM; Delaforge M; Sartori E; Beaune P; Jaouen M; Mansuy D
    Adv Exp Med Biol; 1986; 197():155-62. PubMed ID: 3490132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans.
    Pessayre D; Larrey D; Vitaux J; Breil P; Belghiti J; Benhamou JP
    Biochem Pharmacol; 1982 May; 31(9):1699-704. PubMed ID: 6980648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
    Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
    Delaforge M; Jaouen M; Mansuy D
    Biochem Pharmacol; 1983 Aug; 32(15):2309-18. PubMed ID: 6603844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
    Miura T; Iwasaki M; Komori M; Ohi H; Kitada M; Mitsui H; Kamataki T
    J Antimicrob Chemother; 1989 Oct; 24(4):551-9. PubMed ID: 2515189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic drug interactions with theophylline.
    Jonkman JH; Upton RA
    Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic drug interactions with macrolide antibiotics.
    Descotes J; André P; Evreux JC
    J Antimicrob Chemother; 1985 Jun; 15(6):659-64. PubMed ID: 3897166
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
    Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.
    Pershing LK; Franklin MR
    Xenobiotica; 1982 Nov; 12(11):687-99. PubMed ID: 6984805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide antibacterials. Drug interactions of clinical significance.
    von Rosensteil NA; Adam D
    Drug Saf; 1995 Aug; 13(2):105-22. PubMed ID: 7576262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug interactions with macrolids compared action of two macrolids on liver microsomal activity ].
    Paire M; Lavarenne J
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):535-8. PubMed ID: 6750521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glutathione depletion on the in vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):metabolite complex. Studies with amiodarone and troleandomycin.
    Svensson CK; Drobitch RK; Kloss KA
    J Pharm Sci; 1991 Mar; 80(3):225-8. PubMed ID: 2051337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of midecamycin, a new macrolide antibiotic.
    Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
    G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.